Company Filing History:
Years Active: 2009-2010
Title: The Innovative Mind of Gary A. Decresenzo
Introduction
Gary A. Decresenzo, an accomplished inventor based in St. Charles, MO, has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, his innovative work focuses on tricyclic compounds that affect glucocorticoid receptor activity, potentially impacting the treatment of various medical conditions.
Latest Patents
Gary's latest patents include formulations for tricyclic compounds, specifically designed as modulators of the glucocorticoid receptor. These compounds, as outlined in his patents, are useful in addressing conditions mediated by glucocorticoid receptor activity. The compounds are classified under Formula I or their respective salts, demonstrating promising potential in therapeutic applications.
Career Highlights
Gary A. Decresenzo is associated with Pfizer Corporation, a global leader in pharmaceuticals and biotech. His work at Pfizer emphasizes innovation in drug development, enhancing medical treatments through research and practical application of his patented inventions.
Collaborations
Throughout his career, Gary has collaborated with esteemed colleagues such as Hengmiao (Henry) Cheng and Rajesh Devraj. These partnerships within Pfizer represent a commitment to advancing drug therapies and fostering a collaborative environment for innovative research.
Conclusion
In summary, Gary A. Decresenzo stands as a significant figure in pharmaceutical innovation. His work on tricyclic compounds exemplifies the critical role inventors play in developing new therapeutic solutions. As a key contributor at Pfizer Corporation, his ongoing research continues to open new avenues for medical treatments, thereby improving patient outcomes worldwide.